Jefferies Raises Price Target on Medtronic (MDT) to $100 Following 1Q Report

Go back to Jefferies Raises Price Target on Medtronic (MDT) to $100 Following 1Q Report

Medtronic, on Behalf of Its Subsidiary Heartware International, Inc., Announces Offer to Repurchase HeartWare's 3.50% Convertible Senior Notes Due 2017 and 1.75% Convertible Senior Notes Due 2021

August 26, 2016 8:31 AM EDT

DUBLIN - Aug. 26, 2016 - Medtronic plc (NYSE: MDT), on behalf of its indirect, wholly-owned subsidiary HeartWare International, Inc., today announced that, in connection with the completion of the acquisition of HeartWare by Medtronic, HeartWare has commenced an offer to repurchase (the "Convertible Notes Repurchase Offer"), at the option of each holder, any and all of its outstanding 3.50% Convertible Senior Notes due 2017 (the "2017 Notes") and 1.75% Convertible Senior Notes due 2021 (the "2021 Notes," and... More

Medtronic Reports First Quarter Financial Results

August 25, 2016 6:46 AM EDT

Revenue of $7.2 Billion Decreased 1% as Reported; Prior Year Had Extra Selling Week Revenue Increased Greater than 5 Percent on a Constant Currency, Constant Weeks Basis GAAP Diluted EPS of $0.66; Non-GAAP Diluted EPS of $1.03 GAAP Cash Flow from... More